Table 2 Comparison between the preinjection and the postinjection assessments regarding outcomes measures and procedure assessment
From: Efficacy of neural prolotherapy in treatment of meralgia paresthetica: a case series
Outcomes measures | Preinjection assessment (n = 19 lower limbs from 15 patients)§ | Postinjection assessment (n = 19 lower limbs from 15 patients)§ | Test of significance|| | P |
|---|---|---|---|---|
Overall MP symptoms (VAS)†| 7(7.00 ± 1.49) | 1(1.84 ± 1.80) | -3.848 | ≤ 0.0001* |
MP pain (VAS)†| 6(6.42 ± 1.92) | 1(1.94 ± 1.87) | -3.745 |  ≤ 0.0001* |
MP paresthesia (VAS)†| 7(7.31 ± 1.49) | 1(1.89 ± 2.13) | -3.835 |  ≤ 0.0001* |
MP effect on function and QoL (VAS)†| 5(5.57 ± 1.67) | 0(1.05 ± 1.47) | -3.839 |  ≤ 0.0001* |
Procedure assessment | ||||
Immediately postinjection MP pain (VAS)†| 0(0) | NA | NA | NA |
Injection procedure-induced pain (VAS)†| 2.5(2.44 ± 0.81) | NA | NA | NA |
Presence of injection procedure side effects‡ | NA | 1(5.3) | NA | NA |
Degree of satisfaction regarding the procedure (VAS)†| NA | 8(7.42 ± 2.75) | NA | NA |